Form 4: Tenaya Therapeutics Chief Medical Officer Reports Stock Sale to Cover Tax Obligations
SEC Form 4 Filing
Chief Medical Officer of Tenaya Therapeutics, Whittemore Tingley, reports selling shares to cover tax obligations related to vesting restricted stock units.
Summary
- On May 16, 2025, Whittemore Tingley, the Chief Medical Officer of Tenaya Therapeutics, Inc., reported a transaction involving the company's common stock.
- Tingley sold 2,937 shares of common stock at a price of $0.4427 per share to cover tax withholding obligations related to the vesting of restricted stock units.
- Following the transaction, Tingley beneficially owns 171,856 shares of Tenaya Therapeutics, Inc., common stock, which includes 107,507 shares that will be issued upon the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an insider stock transaction. It doesn't inherently convey positive or negative sentiment, as it simply reports a sale of shares to cover tax obligations.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a sale of shares to cover tax obligations, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| January 24, 2025 | Date of restricted stock units award. |
| May 16, 2025 | Date of stock sale transaction. |
Keywords
Tenaya Therapeutics, TNYA, Whittemore Tingley, Chief Medical Officer, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.